ArticleThyroid research2026
Atrial fibrillation and associated cardiovascular disorders in adults with hyperthyroidism: a retrospective cohort study from two teaching hospitals.
Article in Thyroid research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Overt hyperthyroidism is associated with increased dispersion of ventricular repolarization: a case-control study.Frontiers in endocrinology · 2026Article
- Cardiac electrical remodeling in Graves' disease: insights from global ventricular repolarization indices.Frontiers in endocrinology · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionAtrial fibrillation (AF) is a major cardiovascular complication of thyrotoxicosis but its burden and predictors are poorly described in sub-Saharan Africa. We assessed the prevalence, clinical course, and predictors of AF and related cardiovascular complications in adults with hyperthyroidism at two tertiary hospitals in Addis Ababa, Ethiopia.
methodsRetrospective cohort study of adults (≥ 18 years) with biochemically confirmed hyperthyroidism managed between April 2019 and September 2024. Clinical, ECG and echocardiographic data were abstracted from records; primary outcomes were AF at presentation and persistent AF on follow-up. Associations were examined with multivariable logistic regression.
resultsOf 174 patients (mean age 41.2 ± 11.6 years; 91.9% female), 43 (24.7%) had AF at presentation and 34 (19.5%) remained in persistent AF. Thromboembolic events (echocardiographic contrast n = 2; LV thrombus n = 1; ischemic stroke n = 1) occurred only in persistent AF. Independent predictors of AF included left atrial enlargement (LA ≥ 3.8 cm; AOR 8.6, 95% CI 1.9–38.5), NYHA class III–IV at presentation (AOR 8.9, 95% CI 2.5–33.0), diastolic dysfunction (AOR 5.4, 95% CI 1.4–21.5) and elevated baseline free T3 (AOR 12.5, 95% CI 3.1–50.2). Most patients received propylthiouracil (97.7%) and beta-blockers; anticoagulation was infrequently prescribed (n = 3). Biochemical normalization was slow, and AF was associated with delayed thyroid hormone normalization.
conclusionIn this Ethiopian tertiary-care cohort, AF was common and frequently persistent; elevated thyroid hormone levels and atrial structural changes were strong predictors. Early ECG and targeted echocardiography, prompt restoration of euthyroidism, and guideline-directed anticoagulation for high-risk patients are warranted to reduce thromboembolic and heart-failure complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.